Mitsubishi UFJ Trust & Banking Corp Has $82.96 Million Holdings in McKesson Corporation $MCK

Key Points

• Mitsubishi UFJ Trust & Banking Corp trimmed its McKesson position by 10.1%, selling 11,325 shares to hold 101,133 shares worth $82.96 million (about 0.08% of the company) at the end of the quarter.
• McKesson beat quarterly estimates with EPS of $9.34 (vs. $9.19 expected) and revenue of $106.16 billion (up 11.4% YoY), and set FY2026 guidance of 38.80–39.20 EPS versus analyst consensus of ~39.02.
• The firm declared a quarterly dividend of $0.82 ($3.28 annualized) for a yield of 0.4% and a payout ratio of 9.43%, with an ex-dividend date of June 1 and payment on July 1.

Mitsubishi UFJ Trust & Banking Corp lessened its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 101,133 shares of the company's stock after selling 11,325 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.08% of McKesson worth $82,960,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. GGM Financials LLC acquired a new stake in McKesson during the 3rd quarter worth approximately $25,000. State of Wyoming bought a new stake in McKesson in the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. acquired a new position in shares of McKesson during the 3rd quarter worth approximately $31,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of McKesson during the third quarter worth approximately $33,000. Finally, Board of the Pension Protection Fund bought a new position in shares of McKesson during the fourth quarter worth approximately $33,000. Institutional investors own 85.07% of the company's stock.

McKesson Price Performance

Shares of NYSE:MCK opened at $828.16 on Tuesday. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The stock has a market capitalization of $101.44 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 1.19 and a beta of 0.42. The company's 50 day simple moving average is $902.00 and its 200 day simple moving average is $859.23.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. During the same period in the prior year, the company earned $8.03 earnings per share. The company's quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts anticipate that McKesson Corporation will post 39.02 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson's dividend payout ratio (DPR) is 9.43%.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the transaction, the executive vice president directly owned 2,989 shares of the company's stock, valued at $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company's stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,592 shares of company stock worth $3,518,555 over the last ninety days. Insiders own 0.08% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Wall Street Zen cut McKesson from a "buy" rating to a "hold" rating in a research note on Saturday, April 11th. Barclays raised their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 18th. Weiss Ratings lowered McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. Leerink Partners restated an "outperform" rating and issued a $1,085.00 price target on shares of McKesson in a research report on Thursday, March 5th. Finally, TD Cowen boosted their price target on McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a research note on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, McKesson presently has a consensus rating of "Moderate Buy" and an average target price of $972.27.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.